Cargando…
Autophagy inhibition contributes to Endostar sensitization in esophageal squamous cell carcinoma
Endostar is a novel artificially-synthesized anti-angiogenesis drug, and has been approved for clinical use. Previous studies have indicated that patients with esophageal cancer could benefit from Endostar combined with chemotherapy or chemoradiotherapy. However, the most advantageous use of this dr...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686445/ https://www.ncbi.nlm.nih.gov/pubmed/29163691 http://dx.doi.org/10.3892/ol.2017.7017 |